|
India & Pakistan Prostate Cancer News is an EIN News Service for prostate cancer professionals. Constantly updated news and information about India & Pakistan Prostate Cancer.
Latest India & Pakistan Prostate Cancer News
- Count me among Bozek's "groupies" 2 Dec 2009 04:36 GMT
... outsourcing their research to foreign countries like India." U.S. Rep. Blaine Luetkemeyer, R-St. Elizabeth, Mo., ... that as many as 70 percent of prostate cancers found as a result of PSA testing ... breast cancer victims and nearly one-third of prostate cancer patients a fighting chance of prolonging their ...
- Health Discovery Corporation Appoints Tom Gallagher, Former Wall Street Attorney & a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies 30 Nov 2009 14:20 GMT
... which include those for its new urine-based prostate cancer test with Quest Diagnostics Incorporated (NYSE: DGX) and ... Center, Inc., and traveling to Kolkata (Calcutta), India, and other locations. He also spent a year ...
- Health Discovery Corporation Appoints Tom Gallagher, Former Wall Street Attorney & a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies 30 Nov 2009 14:32 GMT
... which include those for its new urine-based prostate cancer test with Quest Diagnostics Incorporated (NYSE: DGX) and ... Center, Inc., and traveling to Kolkata (Calcutta), India, and other locations. He also spent a year ...
- Health Discovery Corporation Appoints Tom Gallagher, Former Wall Street Attorney & a Vice President at Goldman, Sach 30 Nov 2009 15:12 GMT
... which include those for its new urine-based prostate cancer test with Quest Diagnostics Incorporated (NYSE: DGX) and ... Center, Inc., and traveling to Kolkata (Calcutta), India, and other locations. He also spent a year ...
- Health Discovery Corporation Appoints Tom Gallagher, Former Wall Street Attorney& 30 Nov 2009 16:20 GMT
... which include those for its new urine-based prostate cancer test with Quest Diagnostics Incorporated (NYSE: DGX) and ... Center, Inc., and traveling to Kolkata (Calcutta), India, and other locations. He also spent a year ...
- www.StockMarketingInc.com: Breaking News!!! SRGL "Source Gold Corp. Identifies High Grade Gold and Copper From Initial Sampling Program" 30 Nov 2009 16:25 GMT
... which include those for its new urine-based prostate cancer test with Quest Diagnostics Incorporated (NYSE: DGX) and ... Center, Inc., and traveling to Kolkata (Calcutta), India, and other locations. He also spent a year ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Reimbursement for Its Onko-Sure(TM) in Vitro Diagnostic Cancer Test 3 Dec 2009 19:30 GMT
... Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical ... in US, Canada, Europe, Taiwan, Vietnam and India, places Radient Pharmaceuticals on a path to ... incidence of colorectal, thyroid, female breast, and prostate cancers. The number of cancer deaths has increased ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Reimbursement for Its Onko-Sure(TM) in Vitro Diagnostic Cancer Test (MRW) 3 Dec 2009 19:35 GMT
... Based upon Radient Pharmaceutical's 5-year product sales projections, the Company ... in US, Canada, Europe, Taiwan, Vietnam and India, places on a path to profitability by ... incidence of colorectal, thyroid, female breast, and prostate cancers. The number of cancer deaths has increased ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Reimbursement for Its O 3 Dec 2009 19:35 GMT
... Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical ... in US, Canada, Europe, Taiwan, Vietnam and India, places Radient Pharmaceuticals on a path to ... incidence of colorectal, thyroid, female breast, and prostate cancers. The number of cancer deaths has increased ...
- Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical Testing and Government Rei 3 Dec 2009 20:10 GMT
... Radient Pharmaceuticals Receives Korean FDA Approval for Routine Clinical ... in US, Canada, Europe, Taiwan, Vietnam and India, places Radient Pharmaceuticals on a path to ... incidence of colorectal, thyroid, female breast, and prostate cancers. The number of cancer deaths has increased ...
- KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test 4 Dec 2009 09:32 GMT
... US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) ( : ... in US, Canada, Europe, Taiwan, Vietnam and India, places Radient Pharmaceuticals on a path to ... incidence of colorectal, thyroid, female breast, and prostate cancers. The number of deaths has increased over ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
Prostate Cancer News Today
|